Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment.

Cell Res

Infection Biology Unit, German Primate Center, 37077, Göttingen, Germany.

Published: September 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9436721PMC
http://dx.doi.org/10.1038/s41422-022-00713-yDOI Listing

Publication Analysis

Top Keywords

publisher correction
4
correction dalbavancin
4
dalbavancin novel
4
novel candidate
4
candidate covid-19
4
covid-19 treatment
4
publisher
1
dalbavancin
1
novel
1
candidate
1

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!